CRBU
Price
$1.59
Change
-$0.06 (-3.61%)
Updated
Jun 12 closing price
Capitalization
158.19M
58 days until earnings call
Intraday BUY SELL Signals
SANA
Price
$2.68
Change
-$0.09 (-3.25%)
Updated
Jun 12 closing price
Capitalization
745.82M
46 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRBU vs SANA

Header iconCRBU vs SANA Comparison
Open Charts CRBU vs SANABanner chart's image
CRBU vs SANA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CRBU vs. SANA commentary
Jun 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a Hold and SANA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 14, 2026
Stock price -- (CRBU: $1.60 vs. SANA: $2.68)
Brand notoriety: CRBU and SANA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 136% vs. SANA: 57%
Market capitalization -- CRBU: $158.19M vs. SANA: $745.82M
CRBU [@Biotechnology] is valued at $158.19M. SANA’s [@Biotechnology] market capitalization is $745.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $112.92B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileSANA’s FA Score has 0 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • SANA’s FA Score: 0 green, 5 red.
According to our system of comparison, both CRBU and SANA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 4 TA indicator(s) are bullish while SANA’s TA Score has 4 bullish TA indicator(s).

  • CRBU’s TA Score: 4 bullish, 6 bearish.
  • SANA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both CRBU and SANA are a bad buy in the short-term.

Price Growth

CRBU (@Biotechnology) experienced а -16.93% price change this week, while SANA (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.78%. For the same industry, the average monthly price growth was +90.18%, and the average quarterly price growth was +2050.65%.

Reported Earning Dates

CRBU is expected to report earnings on Aug 11, 2026.

SANA is expected to report earnings on Jul 30, 2026.

Industries' Descriptions

@Biotechnology (+0.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SANA($746M) has a higher market cap than CRBU($158M). CRBU YTD gains are higher at: 0.314 vs. SANA (-34.152). CRBU has higher annual earnings (EBITDA): -116.43M vs. SANA (-192.2M). CRBU has more cash in the bank: 118M vs. SANA (101M). CRBU has less debt than SANA: CRBU (26.9M) vs SANA (75.3M). CRBU has higher revenues than SANA: CRBU (11.2M) vs SANA (0).
CRBUSANACRBU / SANA
Capitalization158M746M21%
EBITDA-116.43M-192.2M61%
Gain YTD0.314-34.152-1%
P/E RatioN/AN/A-
Revenue11.2M0-
Total Cash118M101M117%
Total Debt26.9M75.3M36%
TECHNICAL ANALYSIS
Technical Analysis
CRBUSANA
RSI
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
89%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 14 days ago
80%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
82%
Aroon
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
CRBU
Daily Signal:
Gain/Loss:
SANA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARTQX15.270.12
+0.79%
Artisan Mid Cap Value Investor
TEURX33.220.16
+0.48%
Franklin Mutual International Value C
GSILX23.010.11
+0.48%
Goldman Sachs GQG Ptnrs Intl Opps C
GSPKX19.760.09
+0.46%
Goldman Sachs US Eq Div and Prem Instl
PGIIX20.44N/A
N/A
Polen Global Growth Institutional

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with EDIT. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
-3.92%
EDIT - CRBU
64%
Loosely correlated
+2.46%
CRSP - CRBU
58%
Loosely correlated
-0.86%
RXRX - CRBU
56%
Loosely correlated
N/A
SANA - CRBU
54%
Loosely correlated
-3.25%
BEAM - CRBU
52%
Loosely correlated
-1.29%
More